微生物组与癌症:转化科学综述
本综述汇总临床与临床前证据,提示胃肠道及其他解剖部位(如呼吸道)的微生物可影响癌变、转移、治疗反应及治疗相关不良反应。通过粪菌移植或膳食干预调节肠道微生物,在小型免疫治疗研究中改善结局;而免疫治疗前使用广谱抗生素则与更差的总生存和更高不良反应相关。未来靶向微生物的疗法可能改善癌症患者结局。
要点
- 胃肠道及其他部位微生物可能影响癌变、转移、治疗反应及治疗相关不良反应。
- 粪菌移植或高纤维膳食干预在小型免疫治疗研究中改善结局。
- 免疫治疗前使用广谱抗生素与更差总生存和更高不良反应相关。
核心结论
- 肠道及其他部位微生物可能影响癌症发生发展及治疗不良反应,未来靶向微生物的疗法可能改善癌症患者结局。
研究设计与样本
- 转化科学综述,汇总临床与临床前证据,未报告系统检索范围。
主要发现
- 胃肠道及呼吸道等部位的微生物可能影响癌变、转移、治疗反应及治疗相关不良反应。
- 肿瘤内微生物可能影响治疗反应,减少或消除这些微生物的疗法可能改善癌症患者结局。
- 通过粪菌移植或膳食干预(如高纤维膳食)调节肠道微生物,在小型免疫治疗研究中改善结局。
- 免疫治疗前使用广谱抗生素破坏肠道微生物,与实体瘤免疫检查点阻断治疗及血液恶性肿瘤嵌合抗原受体T细胞治疗患者更差的总生存和更高不良反应发生率相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Growing evidence suggests that microbes located within the gastrointestinal tract and other anatomical locations influence the development and progression of diseases such as cancer. OBSERVATIONS: Clinical and preclinical evidence suggests that microbes in the gastrointestinal tract and other anatomical locations, such as the respiratory tract, may affect carcinogenesis, development of metastases, cancer treatment response, and cancer treatment-related adverse effects. Within tumors of patients with cancer, microbes may affect response to treatment, and therapies that reduce or eliminate these microbes may improve outcomes in patients with cancer. Modulating gastrointestinal tract (gut) microbes through fecal microbiota transplant and other strategies such as dietary intervention (eg, high-fiber diet intervention) has improved outcomes in small studies of patients treated with cancer immunotherapy. In contrast, disruption of the gut microbiota by receipt of broad-spectrum antibiotics prior to treatment with cancer immunotherapy has been associated with poorer overall survival and higher rates of adverse effects in patients treated with immune checkpoint blockade for solid tumors and also with chimeric antigen receptor T-cell therapy for hematologic malignancies. CONCLUSIONS AND RELEVANCE: Microbes in the gut and other locations in the body may influence the development and progression of cancer and may affect the response to adverse effects from cancer therapy. Future therapies targeting microbes in the gut and other locations in the body could potentially improve outcomes in patients with cancer.
引用
- Fernandez E, Wargo JA, Helmink BA, et al. The Microbiome and Cancer: A Translational Science Review. JAMA. 2025. PMID: 40354071. doi:10.1001/jama.2025.2191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。